Cardiovascular disease is the dominant cause of mortality in myositis patients, accounting for up to 55% of deaths. READ MORE

Effective disease self-management for patients requires a patient-provider partnership, and an educational session at ACR Convergence 2020 offered practical steps for providers to encourage lupus patients to succeed at self-management. READ MORE

NBC News medical contributor Natalie Azar, MD, will interview Annual Meeting Planning Committee Basic Science and Clinical Chairs Gregg Silverman, MD, and Diane Kamen, MD, MSCR. READ MORE

As use of immune checkpoint inhibitors increases, so does the number of patients experiencing rheumatologic immune-related adverse events. READ MORE

Checkpoint inhibitors have revolutionized the care of patients with certain cancers; however, patients treated with these therapies often develop immune-related adverse events that strongly resemble rheumatic autoimmune diseases. READ MORE

Imaging plays a critical role in axial spondyloarthritis (axSpA) diagnosis, and three speakers will try to bring greater clarity to imaging issues during Controversies in the Diagnostic Evaluation of Axial Spondyloarthritis: An Experiential Review. READ MORE

Faculty in How I Treat Difficult RA: Panel Session reviewed difficult-to-treat cases for RA patients with ILD, refractory RA, and RA with liver disease. READ MORE

Quantifying the severity of SLE damage remains a challenge, and an ACR Convergence 2020 session discussed issues pertaining to the development of an improved strategy. READ MORE

As more and more patients with rheumatic diseases turn to the digital world for information and support, rheumatologists and their care teams need to know how to guide their patients toward reputable information and away from potentially harmful outcomes. READ MORE

Calcium pyrophosphate (CCP) arthritis was first described more than 50 years ago. Since then, researchers have found that this extremely painful type of arthritis is extraordinarily common but significantly underdiagnosed. READ MORE